189 related articles for article (PubMed ID: 28068631)
1. MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1.
Zhou B; Zhu H; Luo H; Gao S; Dai X; Li Y; Zuo X
Biomed Pharmacother; 2017 Mar; 87():412-418. PubMed ID: 28068631
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
3. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ.
Luo H; Zhu H; Zhou B; Xiao X; Zuo X
Mod Rheumatol; 2015 Jul; 25(4):595-602. PubMed ID: 25547017
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-542-3p Contributes to Apoptosis Resistance in Dermal Fibroblasts from Systemic Sclerosis Patients via Survivin Overexpression.
Vahidi Manesh P; Farazmand A; Gharibdoost F; Vanaki N; Mostafaei S; Kavosi H; Mahmoudi MB; Mahmoudi M
Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):173-181. PubMed ID: 31066253
[TBL] [Abstract][Full Text] [Related]
6. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3.
Honda N; Jinnin M; Kira-Etoh T; Makino K; Kajihara I; Makino T; Fukushima S; Inoue Y; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
Am J Pathol; 2013 Jan; 182(1):206-16. PubMed ID: 23159943
[TBL] [Abstract][Full Text] [Related]
7. Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts.
Tamaki Z; Asano Y; Kubo M; Ihn H; Tada Y; Sugaya M; Kadono T; Sato S
J Dermatol Sci; 2014 Jun; 74(3):251-9. PubMed ID: 24630239
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-27a-3p inhibits lung and skin fibrosis of systemic sclerosis by negatively regulating SPP1.
Cheng Q; Chen M; Wang H; Chen X; Wu H; Du Y; Xue J
Genomics; 2022 Jul; 114(4):110391. PubMed ID: 35644411
[TBL] [Abstract][Full Text] [Related]
9. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
[TBL] [Abstract][Full Text] [Related]
10. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts.
Kajihara I; Jinnin M; Yamane K; Makino T; Honda N; Igata T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
Am J Pathol; 2012 Feb; 180(2):703-14. PubMed ID: 22142808
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression.
Iwamoto N; Vettori S; Maurer B; Brock M; Pachera E; Jüngel A; Calcagni M; Gay RE; Whitfield ML; Distler JH; Gay S; Distler O
Ann Rheum Dis; 2016 Jan; 75(1):303-10. PubMed ID: 25384965
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21 and microRNA-29a modulate the expression of collagen in dermal fibroblasts of patients with systemic sclerosis.
Jafarinejad-Farsangi S; Gharibdoost F; Farazmand A; Kavosi H; Jamshidi A; Karimizadeh E; Noorbakhsh F; Mahmoudi M
Autoimmunity; 2019 May; 52(3):108-116. PubMed ID: 31155965
[TBL] [Abstract][Full Text] [Related]
13. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma.
Sing T; Jinnin M; Yamane K; Honda N; Makino K; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
Rheumatology (Oxford); 2012 Sep; 51(9):1550-6. PubMed ID: 22661558
[TBL] [Abstract][Full Text] [Related]
14. miR-526b targets 3' UTR of MMP1 mRNA.
Kim KH; Jung JY; Son ED; Shin DW; Noh M; Lee TR
Exp Mol Med; 2015 Aug; 47(8):e178. PubMed ID: 26292968
[TBL] [Abstract][Full Text] [Related]
15. MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.
Shi X; Liu Q; Li N; Tu W; Luo R; Mei X; Ma Y; Xu W; Chu H; Jiang S; Du Z; Zhao H; Zhao L; Jin L; Wu W; Wang J
Cell Cycle; 2018; 17(16):1967-1978. PubMed ID: 30145936
[TBL] [Abstract][Full Text] [Related]
16. Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients.
Zhou B; Zuo XX; Li YS; Gao SM; Dai XD; Zhu HL; Luo H
Sci Rep; 2017 Feb; 7():42899. PubMed ID: 28211533
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis.
Chouri E; Servaas NH; Bekker CPJ; Affandi AJ; Cossu M; Hillen MR; Angiolilli C; Mertens JS; van den Hoogen LL; Silva-Cardoso S; van der Kroef M; Vazirpanah N; Wichers CGK; Carvalheiro T; Blokland SLM; Giovannone B; Porretti L; Marut W; Vigone B; van Roon JAG; Beretta L; Rossato M; Radstake TRDJ
J Autoimmun; 2018 May; 89():162-170. PubMed ID: 29371048
[TBL] [Abstract][Full Text] [Related]
18. MiR-16-5p suppresses myofibroblast activation in systemic sclerosis by inhibiting NOTCH signaling.
Yao Q; Xing Y; Wang Z; Liang J; Lin Q; Huang M; Chen Y; Lin B; Xu X; Chen W
Aging (Albany NY); 2020 Dec; 13(2):2640-2654. PubMed ID: 33411678
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MicroRNA-21 induces apoptosis in dermal fibroblasts of patients with systemic sclerosis.
Jafarinejad-Farsangi S; Farazmand A; Gharibdoost F; Karimizadeh E; Noorbakhsh F; Faridani H; Mahmoudi M; Jamshidi AR
Int J Dermatol; 2016 Nov; 55(11):1259-1267. PubMed ID: 27637490
[TBL] [Abstract][Full Text] [Related]
20. Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients.
Lapoirie J; Tran L; Piazza L; Contin-Bordes C; Truchetet ME; Bonnet F
Sci Rep; 2021 Sep; 11(1):18011. PubMed ID: 34504265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
